PrincyNirmalKumarMD
Infectious Disease • Washington, DCAssociate Professor of Medicine, Georgetown University
Dr. Kumar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd Nw
Washington, DC 20007Phone+1 202-687-0845
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 1988 - 1990
Hackensack University Medical Center/Englewood Hospital and Medical CenterResidency, Internal Medicine, 1985 - 1988
Kasturba Medical College ManipalClass of 1980
Certifications & Licensure
DC State Medical License 1988 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- Join now to see all
Clinical Trials
- Antiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected Subjects Start of enrollment: 2006 Jul 01
- A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT Start of enrollment: 2008 Jul 01
- FTC/RPV/TDF on T-Cell Activation, CD4+ T-Cell Count, Inflammatory Biomarkers and Viral Reservoir Start of enrollment: 2013 Apr 25
- Join now to see all
Publications & Presentations
PubMed
- 660 citationsEffect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.Robert L. Gottlieb, Ajay Nirula, Peter Chen, Joseph Boscia, Barry Heller
JAMA. 2021-02-16 - 133 citationsPhase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1.Brinda Emu, Jeffrey Fessel, Shannon Schrader, Princy Kumar, Gary Richmond
The New England Journal of Medicine. 2018-08-16 - 79 citationsFostemsavir in Adults with Multidrug-Resistant HIV-1 InfectionMichael J. Kozal, Judith A. Aberg, Gilles Pialoux, Pedro Cahn, Melanie Thompson
The New England Journal of Medicine. 2020-03-25
Journal Articles
- Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1Princy Kumar, MD, The New England Journal of Medicine
Press Mentions
Kumar Honored for Response, Mentorship During the PandemicApril 29th, 2022- MedStar Health Treats 1000th COVID-19 Patient with Monoclonal Antibody TherapyMarch 17th, 2021
The Cost-Effectiveness and Budget Impact of Ibalizumab-Uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United StatesFebruary 3rd, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
